Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-06

Clinical Trial Update: Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compares ultrasonic drug delivery to standard of care for acute bacterial skin and skin structure infections and non-healing wounds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sonescence, Inc. | Conditions: Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Non-healing Wound | Phase 2 | Status: UNKNOWN